Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1997;30:1223-1231

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Feng, J. J.
Right arrow Articles by Arendshorst, W. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Feng, J. J.
Right arrow Articles by Arendshorst, W. J.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CALCIUM COMPOUNDS
*CALCIUM, ELEMENTAL
*GALLIC ACID
*HEPARIN
Medline Plus Health Information
*High Blood Pressure

(Hypertension. 1997;30:1223-1231.)
© 1997 American Heart Association, Inc.


Articles

Calcium Signaling Mechanisms in Renal Vascular Responses to Vasopressin in Genetic Hypertension

Jian J. Feng; William J. Arendshorst

From the Department of Physiology, University of North Carolina at Chapel Hill.

Abstract Previous blood flow studies demonstrated that arginine vasopressin (AVP) produces exaggerated renal vasoconstriction in young spontaneously hypertensive rats (SHR) compared with Wistar-Kyoto control rats (WKY). The purpose of the present study was to determine the role of postreceptor calcium signaling pathways in AVP-induced renal vasoconstriction in vivo. Renal blood flow (RBF) was measured by electromagnetic flowmetry in anesthetized, water-loaded, 8-week-old WKY and SHR pretreated with indomethacin to avoid interactions with prostaglandins. AVP was injected into the renal artery to produce a transient 25% to 30% decrease in RBF without affecting arterial pressure. To achieve similar control levels of vasoconstriction, SHR received a lower dose (2 versus 5 ng). Coadministration of nifedipine with AVP produced dose-dependent inhibition of the AVP-induced renal vasoconstriction. Nifedipine exerted maximum inhibition by blocking 30% to 35% of the peak AVP response, indicating the involvement of dihydropyridine-sensitive voltage-dependent calcium channels. To evaluate intracellular calcium mobilization, 8-(N,N-diethylamino)octyl-3,4,5-trimethoxybenzoate (TMB-8) or heparin was coadministered with AVP. Each agent produced a dose-dependent inhibition of up to 65% of the maximum blood flow change produced by AVP. The degrees of inhibition produced by maximum effective doses of nifedipine and TMB-8 were additive; the combination blocked up to 85% of the response to AVP. These observations indicate that about one third of the AVP-induced constriction of renal resistance vessels is mediated by voltage-dependent L-type calcium channels responsive to the dihydropyridine nifedipine. Approximately two thirds of the change in vascular tone is due to inositol 1,4,5-trisphosphate–mediated calcium mobilization from intracellular sources sensitive to TMB-8 and heparin. The results suggest that the exaggerated renal vascular reactivity to AVP challenge in SHR is probably not due to a strain difference in postreceptor calcium signal transduction. After AVP receptor stimulation, calcium mobilization and calcium entry signaling pathways participate to similar degrees in WKY and SHR.


Key Words: renal circulation • arterioles • calcium channels • nifedipine • heparin • rats, inbred SHR




This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
L. T. de Richelieu, C. M. Sorensen, N.-H. Holstein-Rathlou, and M. Salomonsson
NO-independent mechanism mediates tempol-induced renal vasodilation in SHR
Am J Physiol Renal Physiol, December 1, 2005; 289(6): F1227 - F1234.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
O. B. Vagnes, F. H. Hansen, J. J. Feng, B. M. Iversen, and W. J. Arendshorst
Enhanced Ca2+ response to AVP in preglomerular vessels from rats with genetic hypertension during different hydration states
Am J Physiol Renal Physiol, June 1, 2005; 288(6): F1249 - F1256.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
F. H. Hansen, O. B. Vagnes, and B. M. Iversen
Enhanced response to AVP in the interlobular artery from the spontaneously hypertensive rat
Am J Physiol Renal Physiol, May 1, 2005; 288(5): F1023 - F1031.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
D. M. Pollock, J. M. Jenkins, A. K. Cook, J. D. Imig, and E. W. Inscho
L-type calcium channels in the renal microcirculatory response to endothelin
Am J Physiol Renal Physiol, April 1, 2005; 288(4): F771 - F777.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
R. W. Fallet, H. Ikenaga, J. P. Bast, and P. K. Carmines
Relative contributions of Ca2+ mobilization and influx in renal arteriolar contractile responses to arginine vasopressin
Am J Physiol Renal Physiol, March 1, 2005; 288(3): F545 - F551.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
O. B. Vagnes, F. H. Hansen, R. E. F. Christiansen, C. Gjerstad, and B. M. Iversen
Age-dependent regulation of vasopressin V1a receptors in preglomerular vessels from the spontaneously hypertensive rat
Am J Physiol Renal Physiol, May 1, 2004; 286(5): F997 - F1003.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
L. Gao, C. Zhu, and E. K. Jackson
alpha 2-Adrenoceptors Potentiate Angiotensin II- and Vasopressin-Induced Renal Vasoconstriction in Spontaneously Hypertensive Rats
J. Pharmacol. Exp. Ther., May 1, 2003; 305(2): 581 - 586.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
M. Salomonsson and W. J. Arendshorst
Norepinephrine-induced calcium signaling pathways in afferent arterioles of genetically hypertensive rats
Am J Physiol Renal Physiol, August 1, 2001; 281(2): F264 - F272.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
O. Vagnes, J. J. Feng, B. M. Iversen, and W. J. Arendshorst
Upregulation of V1 receptors in renal resistance vessels of rats developing genetic hypertension
Am J Physiol Renal Physiol, June 1, 2000; 278(6): F940 - F948.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
M. Salomonsson, K. Brannstrom, and W. J. Arendshorst
alpha 1-Adrenoceptor subtypes in rat renal resistance vessels: in vivo and in vitro studies
Am J Physiol Renal Physiol, January 1, 2000; 278(1): F138 - F147.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
S. K. Fellner and W. J. Arendshorst
Capacitative calcium entry in smooth muscle cells from preglomerular vessels
Am J Physiol Renal Physiol, October 1, 1999; 277(4): F533 - F542.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
M. Salomonsson and W. J. Arendshorst
Calcium recruitment in renal vasculature: NE effects on blood flow and cytosolic calcium concentration
Am J Physiol Renal Physiol, May 1, 1999; 276(5): F700 - F710.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
B. M. Iversen and W. J. Arendshorst
Exaggerated Ca2+ signaling in preglomerular arteriolar smooth muscle cells of genetically hypertensive rats
Am J Physiol Renal Physiol, February 1, 1999; 276(2): F260 - F270.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
B. M. Iversen and W. J. Arendshorst
ANG II and vasopressin stimulate calcium entry in dispersed smooth muscle cells of preglomerular arterioles
Am J Physiol Renal Physiol, March 1, 1998; 274(3): F498 - F508.
[Abstract] [Full Text] [PDF]